Share this article Share this article ROCHESTER, Minn., April 19, 2021 /PRNewswire/ -- Nanodropper, Inc., a medical device company offering a first-of-its-kind eyedrop bottle adaptor that reduces eyedrop size, recently completed a $1.4 million seed round. Golden Seeds, a recognized leader in the movement to accelerate funding to women entrepreneurs, represents Nanodropper's first institutional investor after a multiple-year run of non-dilutive funding through inventor competitions, state and local grant support, and an initial funding round of investors that included optometrists, ophthalmologists, and other healthcare professionals who believe in Nanodropper's product and business model. "Golden Seeds is delighted to be an investor in Nanodropper. We believe the company solves a crucial problem well known by clinicians, payors and most importantly patients. This product is expected to provide much needed precision for glaucoma patients while providing a more cost effective solution for payors," according to Seema Phull, Managing Director of Golden Seeds and member of the Board of Directors of Nanodropper.